1- (4- ((1H- pyrazolo(3,4- d)pyrimidin- 4- yl)oxy)- 2- fluorophenyl)- 3- (4- chloro- 3- (trifluoromethyl)phenyl)urea
inhibits VEGFR-1, VEGFR-2, VEGFR-3, FGFR2, and Src kinase; has antineoplastic activity; structure in first source
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Chen, Li-Juan:
1 article
(12/2014)
|
2. | Chen, Yu-Zong:
1 article
(12/2014)
|
3. | Cheng, Chuan:
1 article
(12/2014)
|
4. | Fu, Xiao-Yu:
1 article
(12/2014)
|
5. | Li, Lin-Li:
1 article
(12/2014)
|
6. | Tang, Yun:
1 article
(12/2014)
|
7. | Wei, Yu-Quan:
1 article
(12/2014)
|
8. | Xiang, Rong:
1 article
(12/2014)
|
9. | Yang, Jiao:
1 article
(12/2014)
|
10. | Yang, Ling-Ling:
1 article
(12/2014)
|
Related Diseases
Related Therapies and Procedures